VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 186 filers reported holding VIKING THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $58,497,777 | -29.4% | 5,284,352 | +3.4% | 0.00% | -50.0% |
| Q2 2023 | $82,871,306 | +22.6% | 5,112,357 | +26.0% | 0.00% | 0.0% |
| Q1 2023 | $67,576,340 | +116.2% | 4,058,639 | +22.0% | 0.00% | +100.0% |
| Q4 2022 | $31,261,308 | +245.0% | 3,325,671 | -0.2% | 0.00% | – |
| Q3 2022 | $9,060,000 | -5.9% | 3,331,089 | 0.0% | 0.00% | – |
| Q2 2022 | $9,627,000 | -12.8% | 3,331,089 | -9.5% | 0.00% | – |
| Q1 2022 | $11,041,000 | -29.1% | 3,680,520 | +8.8% | 0.00% | – |
| Q4 2021 | $15,568,000 | -26.3% | 3,384,167 | +0.6% | 0.00% | -100.0% |
| Q3 2021 | $21,132,000 | +7.5% | 3,364,952 | +2.6% | 0.00% | – |
| Q2 2021 | $19,653,000 | -4.3% | 3,280,810 | +1.1% | 0.00% | -100.0% |
| Q1 2021 | $20,531,000 | +7.7% | 3,246,191 | -4.1% | 0.00% | 0.0% |
| Q4 2020 | $19,055,000 | -1.1% | 3,384,516 | +2.2% | 0.00% | 0.0% |
| Q3 2020 | $19,272,000 | -21.2% | 3,311,233 | -2.4% | 0.00% | 0.0% |
| Q2 2020 | $24,471,000 | +55.4% | 3,394,143 | +0.9% | 0.00% | 0.0% |
| Q1 2020 | $15,744,000 | -38.5% | 3,364,140 | +5.4% | 0.00% | 0.0% |
| Q4 2019 | $25,604,000 | +18.6% | 3,192,470 | +1.7% | 0.00% | 0.0% |
| Q3 2019 | $21,596,000 | -29.7% | 3,138,972 | -15.2% | 0.00% | 0.0% |
| Q2 2019 | $30,709,000 | -0.7% | 3,699,835 | +19.0% | 0.00% | 0.0% |
| Q1 2019 | $30,910,000 | +56.0% | 3,109,641 | +20.1% | 0.00% | 0.0% |
| Q4 2018 | $19,808,000 | -60.5% | 2,589,300 | -10.0% | 0.00% | -50.0% |
| Q3 2018 | $50,123,000 | +122.9% | 2,877,287 | +21.4% | 0.00% | +100.0% |
| Q2 2018 | $22,484,000 | +239.9% | 2,369,190 | +56.5% | 0.00% | – |
| Q1 2018 | $6,614,000 | +65.3% | 1,513,707 | +53.6% | 0.00% | – |
| Q4 2017 | $4,002,000 | +518.5% | 985,752 | +191.0% | 0.00% | – |
| Q3 2017 | $647,000 | +81.2% | 338,789 | +2.4% | 0.00% | – |
| Q2 2017 | $357,000 | -26.1% | 330,689 | 0.0% | 0.00% | – |
| Q1 2017 | $483,000 | +50.0% | 330,689 | +22.4% | 0.00% | – |
| Q4 2016 | $322,000 | +2.9% | 270,222 | +22.7% | 0.00% | – |
| Q3 2016 | $313,000 | +20.8% | 220,296 | +7.2% | 0.00% | – |
| Q2 2016 | $259,000 | +793.1% | 205,575 | +913.9% | 0.00% | – |
| Q1 2016 | $29,000 | -54.7% | 20,275 | +7.4% | 0.00% | – |
| Q4 2015 | $64,000 | -39.6% | 18,875 | +3.3% | 0.00% | – |
| Q3 2015 | $106,000 | -18.5% | 18,275 | 0.0% | 0.00% | – |
| Q2 2015 | $130,000 | – | 18,275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
| Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
| KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
| ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
| Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
| Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
| Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
| L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
| EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |